Cheng Fan

Title: Cheng Fan: Innovator in Lung Cancer Subtyping

Introduction

Cheng Fan is a notable inventor based in Chapel Hill, NC (US), recognized for his contributions to the field of cancer research. He holds a patent that focuses on methods for typing lung cancer, which is crucial for effective treatment and management of the disease. His innovative approach aims to improve the accuracy of lung cancer subtype classification, which can significantly impact patient outcomes.

Latest Patents

Cheng Fan's patent, titled "Methods for typing of lung cancer," provides methods and compositions for the molecular subtyping of lung cancer samples. This patent outlines a method for assessing whether a patient's lung cancer subtype is adenocarcinoma, squamous cell carcinoma, or neuroendocrine, which includes both small cell carcinoma and carcinoid. The methods involve probing the levels of classifier biomarkers at the nucleic acid level in lung cancer samples obtained from patients. Based on the levels of these biomarkers, the lung cancer sample can be classified into a specific subtype, enhancing the precision of diagnosis and treatment.

Career Highlights

Cheng Fan has worked with esteemed institutions, including the University of North Carolina at Chapel Hill and Genecentric Therapeutics, Inc. His work in these organizations has contributed to advancements in cancer research and the development of innovative diagnostic methods.

Collaborations

Cheng has collaborated with notable colleagues such as Gregory Mayhew and Charles M Perou. These partnerships have fostered a collaborative environment that promotes research and innovation in the field of oncology.

Conclusion

Cheng Fan's work in lung cancer subtyping represents a significant advancement in cancer diagnostics. His innovative methods have the potential to improve patient care and treatment outcomes in lung cancer.